SYNERGEN  SYGN TO MAKE DRUG FOR CIBA GEIGY BOULDER COLO MARCH 11 SYNERGEN INC SAID IT AGREED TO PROVIDE ITS HUMAN ELASTASE INHIBITOR DESIGNED TO TREAT EMPHYSEMA TO CIBA GEIGY AG  CIGZ FOR HUMAN CLINICAL TRIALS CIBA GEIGY IS CURRENTLY TESTING THE SUBSTANCE IN ANIMALS BUT THE COMPANY SAID THE NEW SUPPLIES OF THE DRUG WILL BE SUITABLE FOR HUMAN TESTS THE COMPANY SAID CIBA GEIGY INITIALLY LICENSED THE PRODUCT IN 1985 THE NEW AGREEMENT CALLS FOR SYNERGEN TO SET UP A COMMERCIAL MANUFACTURING PROCESS TO PRODUCE THE DRUG AND DELIVER QUANTITIES TO CIBA GEIGY IN THE SECOND HALF 1987   